UFP Technologies has shown strong growth through M&A and organic growth, with a defensive business model in an uncertain economy, making it an appealing investment. The company reported a solid first quarter with a 41% sales increase, despite a slowdown in organic growth due to one-offs and inventory de-stocking. Trading at 21-22 times earnings with manageable leverage, UFP has room for further...
UFP Technologies, Inc. (NASDAQ:UFPT ) Q1 2025 Earnings Conference Call May 6, 2025 10:00 AM ET Company Participants Ron Lataille - Chief Financial Officer Jeff Bailly - Chief Executive Officer & Chairman Conference Call Participants Jaeson Schmidt - Lake Street Brett Fishbin - KeyBanc Justin Ages - CJS Securities Andrew Cooper - Raymond James Operator Good day, and welcome to the UFP Technologi...
NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share ou...
NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open.
NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Ma...
NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. Net sales for 2024 were $504.4 million, 26.1% higher than...
NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th.
UFP Technologies (UFPT -0.47%) has seen its share price grow by 12,040% over the last 25 years, making it a 121-bagger. Had investors held their shares throughout that time, they would have turned a $10,000 investment into more than $1.2 million.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.